Burundi vs Guyana: Incidence of tuberculosis
Incidence of tuberculosis over time
- Burundi
- Guyana
How they compare
Burundi currently reports 83 per 100,000 people against 67 per 100,000 people in Guyana, a difference of 16 per 100,000 people.
That makes Burundi's figure about 1.2 times Guyana's.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Burundi ahead.
Burundi ranks 70th and Guyana ranks 73rd of 208 countries.
Burundi has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burundi | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 189.4 per 100,000 people | 153.2 per 100,000 people | 36.2 per 100,000 people | Burundi |
| 2010s | 127.2 per 100,000 people | 113.1 per 100,000 people | 14.1 per 100,000 people | Burundi |
| 2020s | 89.6 per 100,000 people | 63.8 per 100,000 people | 25.8 per 100,000 people | Burundi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Burundi or Guyana?
- Burundi, at 83 per 100,000 people against 67 per 100,000 people in Guyana as of 2024.
- What is the difference in incidence of tuberculosis between Burundi and Guyana?
- 16 per 100,000 people, with Burundi ahead.
- How many years of comparable data are there for Burundi and Guyana?
- 25 years are reported by both, from 2000 to 2024.
- How do Burundi and Guyana rank globally for incidence of tuberculosis?
- Burundi ranks 70th and Guyana ranks 73rd of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.